Skip to main
NUVL
NUVL logo

Nuvalent (NUVL)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Nuvalent (NUVL) Stock

About Nuvalent (NUVL)

Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC. The company was founded by Matthew D. Shair in January 2017 and is headquartered in Cambridge, MA.
Market cap$5.81B
Yesterday's volume443.04K
Revenue (TTM)
Avg. daily volume547.88K
EBITDA (TTM)-$322.59M
Open$81.30
Price / earnings ratio-18.39x
Yesterday's range$80.26 - $82.29
Debt / equity
52 week range$55.54 - $113.51
5 year debt / equity9.07x
Beta (LTM)1.08x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio14.48x
Ex-dividend date
Next earningsAug 7, 2025
Dividend payable date

Nuvalent Stock Rating

What analysts recommend for NUVL stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 38%
Buy 54%
Hold 8%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 11, 2025, the market cap for Nuvalent stock is $5.82B

The current P/E ratio for Nuvalent stock is -18.39

The 52-week high for Nuvalent stock is $113.51. The current Nuvalent stock price $undefined is 100.00% below its 52-week high

The 52-week low for Nuvalent stock is $55.54. The current Nuvalent stock price $undefined has increased 100.00% from its 52-week low

No, the Nuvalent stock does not pay dividends to its shareholders

The target price for Nuvalent stock is $105.77 based on the average of what a group of analyst think Nuvalent stock could be worth at a future date. This is not a prediction by Public.com

How to buy Nuvalent stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in Nuvalent stock

    Navigate to the Explore page. Then, type Nuvalent into the search bar. When you see Nuvalent stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased Nuvalent stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Nuvalent Stock Earnings

The value each NUVL share was expected to gain vs. the value that each NUVL share actually gained.

Nuvalent (NUVL) reported Q1 2025 earnings per share (EPS) of -$1.18, missing estimates of -$1.06 by 11.32%. In the same quarter last year, Nuvalent's earnings per share (EPS) was -$0.69. Nuvalent is expected to release next earnings on 08/07/2025, with an earnings per share (EPS) estimate of -$1.20.

Buy Nuvalent (NUVL) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.